Vaccines and Public Health: Value Proposition
MSD are passionate in
supporting the UK and
NHS to achieve optimal
public health outcomes.
Addressing inequalities to immunisation access
MSD are committed to working openly and transparently with systems to drive improvements in access to immunisations and we will consider all opportunities to work together that drive towards that goal.
As part of our wider dedication to reducing health inequalities we’d welcome the chance to collaborate with system partners, to find solutions to support equitable access to preventative care.
Exploring localised solutions to support & implement NHS Vaccination Strategy
We’re ready to support implementation of the new Vaccination Strategy and consider ways to offer accessible, innovative and tailored vaccination services.
We see the importance of partnering with systems to identify local challenges, providing customized solutions, and evaluating the effectiveness of services.
Commitment to supporting NHS Immunisation programmes
MSD is proud to have partnered on the UKs National Immunisation Programmes since 1968. Click here for our heritage in vaccine discovery.
By leveraging our joint immunisation expertise, we’re confident that together, we can address and overcome system challenges and access to vaccinations.
For enquiries, please email collaborative@msd.com
Get in touch
Talk to one of the team about challenges you’re facing and find out how we can help
GB-NON-11826 | Date of Preparation: September 2025
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Merck Sharp & Dohme (UK) Limited (Tel: 0208 154 8000).
Merck Sharp & Dohme (UK) Limited Registered Office: 120 Moorgate, London, EC2M 6UR, United Kingdom. Registered in England No. 233687 © 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
GB-NON-11812 | Date of Preparation: September 2025
Hide Footer
